Results 31 to 40 of about 12,721 (210)

Integration of clinical parameters and CT-based radiomics improves machine learning assisted subtyping of primary hyperaldosteronism

Frontiers in Endocrinology, 2023
ObjectivesThe aim of this study was to investigate an integrated diagnostics approach for prediction of the source of aldosterone overproduction in primary hyperaldosteronism (PA).Methods269 patients from the prospective German Conn Registry with PA were
Nabeel Mansour, Andreas Mittermeier, Roman Walter, Balthasar Schachtner, Jan Rudolph, Bernd Erber, Vanessa F. Schmidt, Daniel Heinrich, Denise Bruedgam, Lea Tschaidse, Hanna Nowotny, Martin Bidlingmaier, Sonja L. Kunz, Christian Adolf, Jens Ricke, Martin Reincke, Nicole Reisch, Moritz Wildgruber, Michael Ingrisch   +18 more
doaj   +1 more source

Different pathogenesis of glucose intolerance in two subtypes of primary aldosteronism: Aldosterone‐producing adenoma and idiopathic hyperaldosteronism

Journal of Diabetes Investigation, 2020
Aims/Introduction An increased risk of diabetes mellitus has been reported in primary aldosteronism, but the pathogenesis of glucose intolerance between the primary aldosteronism subtypes remains unclear.
Mikiko Okazaki‐Hada, Ayako Moriya, Mototsugu Nagao, Shinichi Oikawa, Izumi Fukuda, Hitoshi Sugihara   +5 more
doaj   +1 more source

Bartter Syndrome With Normal Aldosterone Level and Acute Pancreatitis: An Unusual Presentation. [PDF]

Clin Case Rep
ABSTRACT Bartter syndrome is a rare autosomal recessive renal tubulopathy, which classically presents with hypokalemic metabolic alkalosis, hyperreninemia, and hyperaldosteronism. We report an atypical presentation in a 16‐year‐old male who was diagnosed following an initial manifestation of acute pancreatitis.
Ayaz N, Ullah M, Ahmad W, Ullah F, Khan IU, Naim F, Naeem A, Sajjad F, Kamil KA.   +8 more
europepmc   +2 more sources

Secondary hypertension as a cause of treatment resistance

Blood Pressure, 2023
In secondary hypertension, elevated blood pressure is caused by a known and/or potentially treatable underlying disease. Although the prevalence of secondary hypertension depends on the patient population and the thoroughness of applied diagnostic ...
Isabella Sudano, Paolo Suter, Felix Beuschlein   +2 more
doaj   +1 more source

Coexistence of Primary Hyperaldosteronism and Graves’ Disease, a Rare Combination of Endocrine Disorders: Is It beyond a Coincidence—A Case Report and Review of the Literature

Case Reports in Endocrinology, 2017
Background. Primary hyperaldosteronism is a known cause for secondary hypertension. In addition to its effect on blood pressure, aldosterone exhibits proinflammatory actions and plays a role in immunomodulation/development of autoimmunity.
S. S. C. Gunatilake, U. Bulugahapitiya
doaj   +1 more source

Pseudo hyperaldosteronism secondary to herbal medicine use

, 2022
Glycyrrhizic acid, better known as licorice, is commonly found in various food and cosmetic products. Excessive consumption is known to cause a syndrome of apparent mineralocorticoid excess or pseudo hyperaldosteronism.
Syed Mohammad Mazhar Uddin, Shapiro, Joshua, Raashid, Sheharyar, Omair Khan, Joshua Shapiro, Kaur, Avleen, Armando Seitillari, Muhammad Hashim, Avleen Kaur, Hashim, Muhammad, Khan, Omair, Uddin, Syed Mohammad Mazhar, Seitillari, Armando, Saipriya Vasudevan, Lu, Tiffany, Vasudevan, Saipriya, Tiffany Lu, Sheharyar Raashid   +17 more
core   +1 more source

New-Onset Atrial Fibrillation in Patients With Primary Aldosteronism Receiving Different Treatment Strategies: Systematic Review and Pooled Analysis of Three Studies

Frontiers in Endocrinology, 2021
BackgroundPrimary aldosteronism (PA) is a common cause of secondary hypertension and associated with higher incidence of new-onset atrial fibrillation (NOAF).
Cheng-Hsuan Tsai, Cheng-Hsuan Tsai, Ya-Li Chen, Chien-Ting Pan, Yen-Tin Lin, Po-Chin Lee, Yu-Wei Chiu, Yu-Wei Chiu, Che-Wei Liao, Zheng-Wei Chen, Chin-Chen Chang, Yi-Yao Chang, Chi-Sheng Hung, Yen-Hung Lin   +13 more
doaj   +1 more source

Confounders of the aldosterone‐to‐renin ratio when used as a screening test in hypertensive patients: A critical analysis of the literature

The Journal of Clinical Hypertension, 2021
The aldosterone‐to‐renin ratio (ARR) is a common screening test for primary aldosteronism in hypertensives. However, there are many factors which could confound the ARR test result and reduce the accuracy of this test.
Gregory P. Veldhuizen, Rawan M. Alnazer, Abraham A. Kroon, Peter W. deLeeuw   +3 more
doaj   +1 more source

Management of Patients With Glucocorticoid-Related Diseases and COVID-19

Frontiers in Endocrinology, 2021
The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a global health crisis affecting millions of people worldwide.
Irina Chifu, Mario Detomas, Ulrich Dischinger, Otilia Kimpel, Felix Megerle, Stefanie Hahner, Martin Fassnacht, Martin Fassnacht, Martin Fassnacht, Barbara Altieri   +9 more
doaj   +1 more source

Aldosterone Immunoassay-Specific Cutoff Value for Seated Saline Suppression Test for Diagnosing Primary Aldosteronism [PDF]

Endocrinology and Metabolism, 2022
A seated saline loading test (SLT) using liquid chromatography-tandem mass spectrometry (LC-MS/MS) is one of the most accepted confirmatory tests of primary aldosteronism.
So Yoon Kwon, Jiyun Park, So Hee Park, So Hyun Cho, You-Bin Lee, Soo-Youn Lee, Jae Hyeon Kim   +6 more
doaj   +1 more source